Jerusalem-based HIL Applied Medical Ltd. announced on Thursday their buyout of Nanolabz Inc., a Nevada-based firm developing smart nano-engineered targets for the short-pulse R&D sector.

According to CEO Sagi Brink-Danan, HIL made their acquisition through an equity agreement wherein Nanolabz’s stakeholders gained ownership of 5% of the Israeli company’s shares.

Read more on Geektime